Study title: Ilowite NT; Pediatrics (United States), Jan 2002, 109(1) p109-15. Current treatment of juvenile rheumatoid arthritis.Ilowite NT; Pediatrics (United States), Jan 2002, 109(1) p109-15. Current treatment of juvenile rheumatoid arthritis.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Musculoskeletal Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: SULFASALAZINE | |||||
ATC code: A07EC01 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |